• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证研究一种新的重建人体表皮模型 EPiTRI 用于 OECD 指导原则下的体外皮肤刺激性试验。

Validation study of a new reconstructed human epidermis model EPiTRI for in vitro skin irritation test according to OECD guidelines.

机构信息

Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute (ITRI), Taiwan, ROC.

Japanese Center for the Validation of Alternative Methods (JaCVAM), National Institute of Health Sciences (NIHS), Japan.

出版信息

Toxicol In Vitro. 2021 Sep;75:105197. doi: 10.1016/j.tiv.2021.105197. Epub 2021 May 29.

DOI:10.1016/j.tiv.2021.105197
PMID:34062233
Abstract

Following the global trend of reducing animal testing, various reconstructed human epidermis (RHE) models for skin irritation test (SIT) have been developed, verified, validated and included in OECD TG 439. We developed a new RHE called EPiTRI and a SIT method using EPiTRI (EPiTRI-SIT model) following the OECD guidelines. EPiTRI possesses morphological, biochemical and physiological properties similar to human epidermis with well-differentiated multilayered viable cells with barrier function. The EPiTRI-SIT model was tested for 20 reference chemicals in Performance Standard of OECD TG 439 (GD 220), showing good predictive capacity with 100% sensitivity, 70% specificity and 85% accuracy. EPiTRI had sensitivity in detecting di-n-propyl disulphate, as an irritant chemical (UN GHS Category 2), whereas most validated reference methods detected it as a non-irritant. An international validation study of EPiTRI-SIT was conducted in four laboratories to confirm the within- and between-laboratory reproducibility, as well as predictive capacity. The phase I/II within-laboratory and between-laboratory reproducibility was 100%/95% and 95%, respectively. The overall sensitivity, specificity and accuracy of EPiTRI-SIT was 96%, 70% and 83%, respectively, which fulfilled the OECD criteria. Thus, EPiTRI, meets the criteria of Performance Standards of OECD TG 439 (GD 220) and is suitable for screening irritating chemicals in vitro.

摘要

随着全球减少动物试验的趋势,已经开发、验证、确认了各种用于皮肤刺激试验(SIT)的重建人体表皮(RHE)模型,并将其纳入了 OECD TG 439。我们按照 OECD 指南开发了一种新的 RHE,称为 EPiTRI,并开发了一种使用 EPiTRI 的 SIT 方法(EPiTRI-SIT 模型)。EPiTRI 具有与人类表皮相似的形态、生化和生理特性,具有具有屏障功能的分化良好的多层活细胞。EPiTRI-SIT 模型在 OECD TG 439 的性能标准(GD 220)中对 20 种参考化学品进行了测试,具有良好的预测能力,敏感性为 100%,特异性为 70%,准确性为 85%。EPiTRI 对二丙基二硫硫酸盐(UN GHS 类别 2 的刺激性化学品)具有敏感性,而大多数经过验证的参考方法将其检测为非刺激性化学品。在四个实验室中进行了 EPiTRI-SIT 的国际验证研究,以确认实验室内部和实验室之间的重现性以及预测能力。第一阶段/第二阶段实验室内部和实验室之间的重现性分别为 100%/95%和 95%。EPiTRI-SIT 的整体敏感性、特异性和准确性分别为 96%、70%和 83%,符合 OECD 标准。因此,EPiTRI 符合 OECD TG 439 性能标准(GD 220)的标准,适合用于体外筛选刺激性化学品。

相似文献

1
Validation study of a new reconstructed human epidermis model EPiTRI for in vitro skin irritation test according to OECD guidelines.验证研究一种新的重建人体表皮模型 EPiTRI 用于 OECD 指导原则下的体外皮肤刺激性试验。
Toxicol In Vitro. 2021 Sep;75:105197. doi: 10.1016/j.tiv.2021.105197. Epub 2021 May 29.
2
KeraSkin-VM: a novel reconstructed human epidermis model for skin irritation tests.KeraSkin-VM:一种用于皮肤刺激性测试的新型重组人表皮模型。
Toxicol In Vitro. 2014 Aug;28(5):742-50. doi: 10.1016/j.tiv.2014.02.014. Epub 2014 Mar 10.
3
Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkin™ for OECD test guideline 439.用于 OECD 测试指南 439 的体外皮肤刺激试验的同型物验证研究,使用 KeraSkin™ 人体重建表皮模型。
Regul Toxicol Pharmacol. 2020 Nov;117:104725. doi: 10.1016/j.yrtph.2020.104725. Epub 2020 Aug 5.
4
A new reconstructed human epidermis for in vitro skin irritation testing.一种用于体外皮肤刺激性测试的新型重建人表皮。
Toxicol In Vitro. 2017 Aug;42:31-37. doi: 10.1016/j.tiv.2017.03.010. Epub 2017 Mar 23.
5
Validation study for in vitro skin irritation test using reconstructed human skin equivalents constructed by layer-by-layer cell coating technology.采用层层细胞涂覆技术构建的重组人皮肤等效物的体外皮肤刺激性试验验证研究。
J Appl Toxicol. 2023 Jun;43(6):874-886. doi: 10.1002/jat.4431. Epub 2023 Feb 15.
6
A catch-up validation study of an in vitro skin irritation test method using reconstructed human epidermis LabCyte EPI-MODEL24.一项使用重组人表皮LabCyte EPI - MODEL24进行体外皮肤刺激试验方法的追赶验证研究。
J Appl Toxicol. 2014 Jul;34(7):766-74. doi: 10.1002/jat.2937. Epub 2013 Oct 10.
7
Catch-up validation study of an in vitro skin irritation test method based on an open source reconstructed epidermis (phase II).基于开源重组表皮的体外皮肤刺激试验方法的追赶验证研究(第二阶段)。
Toxicol In Vitro. 2016 Oct;36:254-261. doi: 10.1016/j.tiv.2016.07.008. Epub 2016 Jul 17.
8
An integrated testing strategy for in vitro skin corrosion and irritation assessment using SkinEthic™ Reconstructed Human Epidermis.一种使用SkinEthic™ 重组人表皮进行体外皮肤腐蚀性和刺激性评估的综合测试策略。
Toxicol In Vitro. 2015 Oct;29(7):1779-92. doi: 10.1016/j.tiv.2015.07.012. Epub 2015 Jul 14.
9
Catch-up validation study of an in vitro skin irritation test method based on an open source reconstructed epidermis (phase I).基于开源重建表皮的体外皮肤刺激试验方法的追赶验证研究(第一阶段)。
Toxicol In Vitro. 2016 Oct;36:238-253. doi: 10.1016/j.tiv.2016.07.007. Epub 2016 Jul 16.
10
Sub-categorisation of skin corrosive chemicals by the EpiSkin™ reconstructed human epidermis skin corrosion test method according to UN GHS: revision of OECD Test Guideline 431.根据联合国全球化学品统一分类和标签制度(UN GHS),利用 EpiSkin™ 重建人体表皮皮肤腐蚀性测试方法对皮肤腐蚀性化学品进行亚分类:对 OECD 测试指南 431 的修订。
Toxicol In Vitro. 2014 Mar;28(2):131-45. doi: 10.1016/j.tiv.2013.10.016. Epub 2013 Nov 5.

引用本文的文献

1
Skin irritation testing using human iPSCs derived 3D skin equivalent model.使用源自人诱导多能干细胞的3D皮肤等效模型进行皮肤刺激性测试。
PLoS One. 2025 Aug 18;20(8):e0330306. doi: 10.1371/journal.pone.0330306. eCollection 2025.
2
Pre-validation of a novel reconstructed skin equivalent model for skin irritation and nanoparticle risk assessment.一种用于皮肤刺激和纳米颗粒风险评估的新型重建皮肤等效模型的预验证
Nanoscale Adv. 2025 Jan 8;7(5):1353-1367. doi: 10.1039/d4na00804a. eCollection 2025 Feb 25.
3
A human skin-on-a-chip platform for microneedling-driven skin cancer treatment.
一种用于微针驱动皮肤癌治疗的人体芯片皮肤平台。
Mater Today Bio. 2024 Dec 10;30:101399. doi: 10.1016/j.mtbio.2024.101399. eCollection 2025 Feb.
4
How to facilitate the implementation of 3D models in China by applying good method practice for regulatory use.如何通过应用良好的监管使用方法实践来促进3D模型在中国的实施。
Front Toxicol. 2023 Mar 8;5:1080528. doi: 10.3389/ftox.2023.1080528. eCollection 2023.
5
Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling.用于疾病建模的全层自组装皮肤等效物的结构和功能验证
Pharmaceutics. 2022 Jun 7;14(6):1211. doi: 10.3390/pharmaceutics14061211.